Gregory Lip
Gregory Lip is a clinical researcher and [https://www.liverpool.ac.uk/health-and-life-sciences/staff/gregory-lip/ Price-Evans Chair of Cardiovascular Medicine], at the University of Liverpool. He is director of the [https://www.liverpool.ac.uk/health-and-life-sciences/lccs/ Liverpool Centre for Cardiovascular Science] at the University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital.He is a NIHR senior investigator, and also distinguished professor at Aalborg University, Denmark; and adjunct professor at Yonsei University and Seoul National University, Seoul, Korea. He also holds visiting or honorary professorships in various other universities in UK, Serbia (Belgrade), S.Korea (Yonsei, Seoul National University), China (Beijing, Nanjing, Guangzhou), Thailand (Chiangmai, Mahidol in Bangkok) and Taiwan (Taipei).
He is one of the top highly-cited researchers (h>100) according to webometrics. and [https://www.adscientificindex.com/scientist.php?id=1590656 AD Scientific Index Rankings]. However, the extremely rapid pace of his scientific output has been questioned.
Professor Lip has had a major interest into the epidemiology of atrial fibrillation (AF), as well as the pathophysiology of thromboembolism in this arrhythmia. Furthermore, he has been researching stroke and bleeding risk factors, and improvements in clinical risk stratification. The CHA2DS2-VASc and HAS-BLED scores - for assessing stroke and bleeding risk, respectively – were first proposed and independently validated following his research. The ABC (Atrial fibrillation Better Care) pathway management approach proposed by him is the core recommendation in various AF guidelines, and has been shown to reduce adverse outcomes in AF patients. His work has led to changes in national and international clinical practice guidelines and improvements in patient care.
Professor Lip was ranked by Expertscape as a [https://www.prlog.org/12273752-expertscape-ranks-top-doctors-and-hospitals-in-atrial-fibrillation.html leading expert in the understanding and treatment of AF], a position still [https://expertscape.com/ex/atrial+fibrillation maintained in 2023]. In 2023, he was awarded the American College of Cardiology (ACC) [https://www.acc.org/Latest-in-Cardiology/Articles/2023/01/03/18/38/Announcing-ACCs-2023-Distinguished-Awardees Distinguished Scientist Award (Clinical Domain)].
He was on the writing committee for various international guidelines, including the American College of Chest Physicians (ACCP) Antithrombotic Therapy Guidelines for Atrial Fibrillation, as well as various guidelines and/or position statements from the European Society of Cardiology (ESC) or European Heart Rhythm Association. He has acted as senior/section editor for major international textbooks and at senior editorial level for major international journals. Provided by Wikipedia
Showing 1 - 20 results of 354 for search 'Gregory Y. H. Lip', query time: 0.08s
Refine Results
-
1
Managing high-risk atrial fibrillation patients with multiple comorbidities by Gregory Y. H. Lip
Published 2023-02-01
Article -
2
Atrial Fibrillation in Older People: Concepts and Controversies by Zafraan Zathar, Anne Karunatilleke, Ameenathul M. Fawzy, Gregory Y. H. Lip, Gregory Y. H. Lip
Published 2019-08-01
Article -
3
Introducing Our New Offspring Journal … TH Open by Gregory Y. H. Lip, Christian Weber
Published 2017-06-01
Article -
4
Disparities in atrial fibrillation: a call for holistic care by Agnieszka Kotalczyk, Gregory Y.H. Lip
Published 2021-08-01
Article -
5
Alcohol and Atrial Fibrillation by Stanisław Surma, Gregory Y.H. Lip
Published 2023-03-01
Article -
6
Stroke Prevention in Atrial Fibrillation: Where are We Now? by Yousif Ahmad, Gregory Y.H. Lip
Published 2012-01-01
Article -
7
-
8
Stroke Prevention in Atrial Fibrillation: Where are We Now? by Yousif Ahmad, Gregory Y.H. Lip
Published 2012-02-01
Article -
9
Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis by Tae-Min Rhee, So-Ryoung Lee, Eue-Keun Choi, Eue-Keun Choi, Seil Oh, Seil Oh, Gregory Y. H. Lip, Gregory Y. H. Lip, Gregory Y. H. Lip
Published 2022-06-01
Article -
10
Cardiovascular disease prevention: Risk factor modification at the heart of the matter by Ameenathul M. Fawzy, Gregory Y.H. Lip
Published 2021-12-01
Article -
11
-
12
Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study by Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Eue-Keun Choi, Seung-Woo Lee, Jin-Hyung Jung, Kyung-Do Han, Hyo-Jeong Ahn, Seil Oh, Seil Oh, Gregory Y. H. Lip, Gregory Y. H. Lip, Gregory Y. H. Lip, Gregory Y. H. Lip
Published 2023-10-01
Article -
13
-
14
Monocytes are increased in pregnancy after gestational hypertensive disease by James S. Castleman, Gregory Y. H. Lip, Eduard Shantsila
Published 2022-06-01
Article -
15
Endotoxemia as a trigger of thrombosis in cirrhosis by Francesco Violi, Gregory Y.H. Lip, Roberto Cangemi
Published 2016-04-01
Article -
16
Role of Monocytes in Heart Failure and Atrial Fibrillation by Farhan Shahid, Gregory Y.H. Lip, Eduard Shantsila
Published 2018-02-01
Article -
17
Antithrombotic therapy in chronic liver disease: to clot or not to clot by Peter Calvert, Dhiraj Gupta, Gregory Y.H. Lip
Published 2021-11-01
Article -
18
Emerging Tools for Stroke Prevention in Atrial Fibrillation by Christos Voukalis, Gregory Y.H. Lip, Eduard Shantsila
Published 2016-02-01
Article -
19
-
20
Stroke prevention in atrial fibrillation: Where are we now? by Gregory Y.H. Lip, MD, FRCP, FESC, FACC
Published 2015-12-01
Article